期刊文献+

α-干扰素肿瘤抗性相关分子标志物的研究进展 被引量:2

Advance in research of tumor molecular markers related to IFN-α resistance
下载PDF
导出
摘要 α-干扰素(interferon-α,IFN-α)是一种重要的治疗性细胞因子,通过调节细胞周期、抑制原癌基因、调控细胞黏附和血管生成等机制发挥抗肿瘤效应。然而患者对IFN-α反应性的差异限制了其在临床的广泛使用。信号转导通路中一些关键因子如STAT1、STAT3、P48、SOCS1等的异常表达,与肿瘤的IFN-α抗性机制相关;某些原癌基因Bcl-2、c-myc、EVI-1等的过度表达也参与IFN-α抗性形成;此外DNA甲基转移酶、组蛋白修饰与肿瘤IFN-α抗性的发生密切相关。因此,对这些预测IFN-α临床疗效有潜在价值的分子标志物进行多因素分析,选择适合IFN-α治疗的敏感病例,设计个体化的治疗方案,将成为今后肿瘤治疗的一个发展方向。
作者 荆妮 吕秋军
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2009年第2期203-206,共4页 Chinese Journal of Cancer Biotherapy
  • 相关文献

参考文献32

  • 1Gauzzi MC, Barbieri G, Richter MF, et al. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor [ J ]. Proc Natl Acad Sci U S A, 1997, 94(22) :11839-11844.
  • 2Shang D, Liu Y, Ito N, et al. Defective JAK-STAT activation in renal cell carcinoma is associated with interferon-alpha resistance [J]. CancerSci, 2007, 98(8) :1259-1264.
  • 3Wong LH, Krauer KG, Hatzinisiriou I, et al. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1 ,STAT2, and p48-ISGF3gamma[ J]. J Biol Chem, 1997, 272 (45) :28779-28785.
  • 4Sun WH, Pabon C, Alsayed Y, et al. Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression[J]. Blood, 1998, 91(2) : 570-576.
  • 5Abril E, Real LM, Serrano A, et al. Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line[ J]. Cancer lmmuno Immunother, 1998,47(2) : 113-120.
  • 6Landolfo S, Guarini A, Riera L, et al. Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression [ J ]. Hematol J, 2000, 1(1) : 7-14.
  • 7Yang CH, Murti A, Pfeffer LM. STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STA33 in interferon signaling and biological activities [ J ]. Proc Natl Acad Sci U S A, 1998, 95(10) : 5568-5572.
  • 8Ito N, Eto M, Nakamura E, et al. STAT3 polymorpohism predicts interferon-alpha response in patients with metastatic renal cell carcinoma[J]. ] Clin Oncol, 2007, 25(19) : 2785-2791.
  • 9Matikainen S, Ronni T, Lehtonen A, et al. Retinoic acid induces signal transducer and activator of transcription(STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons [ J]. Cell Growth Differ, 1997, 8 (6) : 687-698.
  • 10Wu WZ, Sun HC, Gao YQ, et al. Reduction in p48-1SGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells [J]. Oncology, 2004, 67(5-6): 428440.

同被引文献18

  • 1HEKMAN A C,TRAPMAN J,MULDER A H,et al.Interferon expression in the testes of transgenic mice leads to sterility[J].J Biol Chem,1988,263(24):12151 -12155.
  • 2GILLESPIE D,CARTER W A.Species-specificity of interferon[J].Tex Rep Biol Med,1981,41:37 -42.
  • 3ZINN K,MELLON P,PTASHNE M,et al.Regulated expression of an extrachromosomal human beta-interferon gene in mouse cells[J].Proc Natl Acad Sci USA,1982,79(2):4897 -4901.
  • 4CHEN X Z,YUN J S,WAGNER T E.Enhanced viral resistance in transgenic mice expressing the human beta 1 interferon[J].J Virol,1988,62(10):3883 -3887.
  • 5WECK P K,RINDERKNECHT E,KSTELL D A,et al.Antiviral activity of bacteria-derived human alpha interferons against encephalomyocarditis virus infection of mice[J].InfectImmun,1982,35(15):660 -665.
  • 6Bowan T,Garcia R,Tukson J, et al. STATs in oncogenesis. On- cogene, 2000, 19 : 2474-2488.
  • 7李建,李宁,费哲为,等.5氟尿嘧啶联合干扰素α对胃癌细胞的影响.现代肿瘤学杂志,2008,16:1072-1074.
  • 8Takaoka A, Hayakawa S, Yanai H, et al. Integration of interfer on alpha/beta signaling to p53 responses in tumor suppression and antiviral defenee. Nature, 2003,424 : 516-523.
  • 9Stephanou A, Latehman DS. STAT-1 : a novel regulator of apop- tosis. Int J Exp Pathol, 2003,84 : 239-244.
  • 10Brassard DL,Grace M J, Bordens RW. Interferon alpha as an im- munotherapeutic protein. J Leukoc Biot,2002,71:565-581.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部